Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study

Introduction The INflammation and Small Vessel Disease (INSVD) study aims to investigate whether peripheral inflammation, immune (dys)regulation and blood–brain barrier (BBB) permeability relate to disease progression in cerebral small vessel disease (SVD). This research aims to pinpoint specific co...

Full description

Bibliographic Details
Main Authors: Roy P C Kessels, Audrey Low, Hugh Markus, Anil Tuladhar, Frank‐Erik de Leeuw, Robin G Morris, Ziad Mallat, Niels P Riksen, Daniel J Tozer, Sanne van Winden, Lupei Cai, Marnix C Maas, Meritxell Nus, Anja van der Kolk, Rowan Wolters
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/2/e084303.full
_version_ 1797257546516398080
author Roy P C Kessels
Audrey Low
Hugh Markus
Anil Tuladhar
Frank‐Erik de Leeuw
Robin G Morris
Ziad Mallat
Niels P Riksen
Daniel J Tozer
Sanne van Winden
Lupei Cai
Marnix C Maas
Meritxell Nus
Anja van der Kolk
Rowan Wolters
author_facet Roy P C Kessels
Audrey Low
Hugh Markus
Anil Tuladhar
Frank‐Erik de Leeuw
Robin G Morris
Ziad Mallat
Niels P Riksen
Daniel J Tozer
Sanne van Winden
Lupei Cai
Marnix C Maas
Meritxell Nus
Anja van der Kolk
Rowan Wolters
author_sort Roy P C Kessels
collection DOAJ
description Introduction The INflammation and Small Vessel Disease (INSVD) study aims to investigate whether peripheral inflammation, immune (dys)regulation and blood–brain barrier (BBB) permeability relate to disease progression in cerebral small vessel disease (SVD). This research aims to pinpoint specific components of the immune response in SVD relating to disease progression. This could identify biomarkers of SVD progression, as well as potential therapeutic targets to inform the development and repurposing of drugs to reduce or prevent SVD, cognitive decline and vascular dementia.Methods and analysis INSVD is a prospective observational multicentre cohort study in individuals with symptomatic SVD. This longitudinal study combines comprehensive immunophenotyping of the peripheral blood immune compartment with advanced neuroimaging markers of SVD and BBB permeability. The main SVD marker of interest is white matter microstructure as determined by diffusion tensor imaging, a valuable marker of disease progression owing to its sensitivity to early alterations to white matter integrity. The research is being conducted in two sites—in the UK (Cambridge) and the Netherlands (Nijmegen)—with each site recruiting 100 participants (total n=200). Participants undergo clinical and cognitive assessments, blood draws, and brain MRI at baseline and 2-year follow-up.Ethics and dissemination This study received ethical approval from the local ethics boards (UK: East of England—Cambridge Central Research Ethics Committee (REC) ref: 22/EE/00141, Integrated Research Application System (IRAS) ID: 312 747. Netherlands: Medical Research Ethics Committee (MREC) Oost-Nederland, ref: 2022-13623, NL-number: NL80258.091.22). Written informed consent was obtained from all subjects before the study. Any participant-derived benefits resulting from this research, such as new insights into disease mechanisms or possible novel therapies, will be disseminated to study participants, patient groups and members of the public.Trial registration number NCT05746221.
first_indexed 2024-03-07T21:24:07Z
format Article
id doaj.art-9de6a34a9f7443a3934e4e2d8c33f96d
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-04-24T22:39:22Z
publishDate 2024-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-9de6a34a9f7443a3934e4e2d8c33f96d2024-03-19T05:30:08ZengBMJ Publishing GroupBMJ Open2044-60552024-02-0114210.1136/bmjopen-2024-084303Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort studyRoy P C Kessels0Audrey Low1Hugh Markus2Anil Tuladhar3Frank‐Erik de Leeuw4Robin G Morris5Ziad Mallat6Niels P Riksen7Daniel J Tozer8Sanne van Winden9Lupei Cai10Marnix C Maas11Meritxell Nus12Anja van der Kolk13Rowan Wolters14Vincent Van Gogh Instituut, Venray, The NetherlandsDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsInstitute of Psychiatry, Psychology and Neuroscience (IoPPN), King`s College London, London, UKThe Victor Phillip Dahdaleh Heart and Lung Research Institute, Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge Medicine, Cambridge, UKDepartment of Internal Medicine, Radboudumc, Nijmegen, The NetherlandsDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The NetherlandsDivision of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UKDepartment of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The NetherlandsDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsIntroduction The INflammation and Small Vessel Disease (INSVD) study aims to investigate whether peripheral inflammation, immune (dys)regulation and blood–brain barrier (BBB) permeability relate to disease progression in cerebral small vessel disease (SVD). This research aims to pinpoint specific components of the immune response in SVD relating to disease progression. This could identify biomarkers of SVD progression, as well as potential therapeutic targets to inform the development and repurposing of drugs to reduce or prevent SVD, cognitive decline and vascular dementia.Methods and analysis INSVD is a prospective observational multicentre cohort study in individuals with symptomatic SVD. This longitudinal study combines comprehensive immunophenotyping of the peripheral blood immune compartment with advanced neuroimaging markers of SVD and BBB permeability. The main SVD marker of interest is white matter microstructure as determined by diffusion tensor imaging, a valuable marker of disease progression owing to its sensitivity to early alterations to white matter integrity. The research is being conducted in two sites—in the UK (Cambridge) and the Netherlands (Nijmegen)—with each site recruiting 100 participants (total n=200). Participants undergo clinical and cognitive assessments, blood draws, and brain MRI at baseline and 2-year follow-up.Ethics and dissemination This study received ethical approval from the local ethics boards (UK: East of England—Cambridge Central Research Ethics Committee (REC) ref: 22/EE/00141, Integrated Research Application System (IRAS) ID: 312 747. Netherlands: Medical Research Ethics Committee (MREC) Oost-Nederland, ref: 2022-13623, NL-number: NL80258.091.22). Written informed consent was obtained from all subjects before the study. Any participant-derived benefits resulting from this research, such as new insights into disease mechanisms or possible novel therapies, will be disseminated to study participants, patient groups and members of the public.Trial registration number NCT05746221.https://bmjopen.bmj.com/content/14/2/e084303.full
spellingShingle Roy P C Kessels
Audrey Low
Hugh Markus
Anil Tuladhar
Frank‐Erik de Leeuw
Robin G Morris
Ziad Mallat
Niels P Riksen
Daniel J Tozer
Sanne van Winden
Lupei Cai
Marnix C Maas
Meritxell Nus
Anja van der Kolk
Rowan Wolters
Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
BMJ Open
title Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
title_full Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
title_fullStr Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
title_full_unstemmed Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
title_short Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
title_sort immune regulation and blood brain barrier permeability in cerebral small vessel disease study protocol of the inflammation and small vessel disease insvd study a multicentre prospective cohort study
url https://bmjopen.bmj.com/content/14/2/e084303.full
work_keys_str_mv AT roypckessels immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT audreylow immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT hughmarkus immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT aniltuladhar immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT frankerikdeleeuw immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT robingmorris immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT ziadmallat immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT nielspriksen immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT danieljtozer immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT sannevanwinden immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT lupeicai immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT marnixcmaas immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT meritxellnus immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT anjavanderkolk immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy
AT rowanwolters immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy